High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$25.6M
$25,550,000
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
LRMR
P
Larimar Therapeutics, Inc.
Flynn James E
• Director
Discretionary BuyΔOwn +11.4%
2026-02-27
$5,420,050Whale
|
||||||
| LRMR |
Larimar Therapeutics, Inc.
|
Director
Discretionary BuyΔOwn +11.4%
|
2026-02-27 | $5,420,050Whale | P | Form 4 |
|
LRMR
P
Larimar Therapeutics, Inc.
Flynn James E
• Director
Discretionary BuyΔOwn +11.4%
2026-02-27
$5,420,060Whale
|
||||||
| LRMR |
Larimar Therapeutics, Inc.
|
Director
Discretionary BuyΔOwn +11.4%
|
2026-02-27 | $5,420,060Whale | P | Form 4 |
|
LRMR
P
Larimar Therapeutics, Inc.
Flynn James E
• Director
Discretionary BuyΔOwn +11.4%
2026-02-27
$4,159,890Large
|
||||||
| LRMR |
Larimar Therapeutics, Inc.
|
Director
Discretionary BuyΔOwn +11.4%
|
2026-02-27 | $4,159,890Large | P | Form 4 |
|
LRMR
P
Larimar Therapeutics, Inc.
Flynn James E
• Director
Discretionary BuyΔOwn +47.5%
2026-02-27
$10,000,000MEGA
|
||||||
| LRMR |
Larimar Therapeutics, Inc.
|
Director
Discretionary BuyΔOwn +47.5%
|
2026-02-27 | $10,000,000MEGA | P | Form 4 |
| LRMR |
Larimar Therapeutics, Inc.
|
Director
Discretionary Buy
|
2026-02-27 | $25,000 | P | Form 4 |
|
LRMR
P
Larimar Therapeutics, Inc.
THOMAS FRANK E
• Director
Discretionary BuyΔOwn +250.0%
2026-02-27
$25,000
|
||||||
| LRMR |
Larimar Therapeutics, Inc.
|
Director
Discretionary BuyΔOwn +250.0%
|
2026-02-27 | $25,000 | P | Form 4 |
|
LRMR
P
Larimar Therapeutics, Inc.
Hamilton Thomas Edward
• Director
Discretionary BuyΔOwn +17.7%
2026-02-27
$500,000
|
||||||
| LRMR |
Larimar Therapeutics, Inc.
|
Director
Discretionary BuyΔOwn +17.7%
|
2026-02-27 | $500,000 | P | Form 4 |